Duane D Miller Selected Research

1,2,3,4-tetrahydroisoquinoline

9/2014	EDL-360: A Potential Novel Antiglioma Agent.
6/2012	EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo.
5/2009	Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL-155, a novel antitumor agent for retinoblastoma in rats.
12/2008	Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.
10/2008	Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma.
9/2006	Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Duane D Miller Research Topics

Disease

76	Neoplasms (Cancer) 01/2022 - 04/2006
35	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 08/2002
23	Melanoma (Melanoma, Malignant) 01/2021 - 03/2007
18	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2006
7	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2010
7	Inflammation (Inflammations) 01/2017 - 01/2013
7	Glioma (Gliomas) 09/2014 - 07/2003
6	Osteoporosis 02/2021 - 10/2005
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2009
4	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2008
3	Triple Negative Breast Neoplasms 01/2022 - 01/2014
3	Fibrosis (Cirrhosis) 12/2021 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 01/2009
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017 - 03/2014
3	Obesity 01/2017 - 10/2010
3	Acute Radiation Syndrome 04/2015 - 11/2011
3	Retinoblastoma (Glioblastoma, Retinal) 09/2013 - 05/2009
2	Necrosis 01/2020 - 11/2016
2	Weight Gain 01/2017 - 03/2012
2	Retinal Neovascularization 01/2017 - 01/2017
2	Body Weight (Weight, Body) 01/2017 - 10/2014
2	Pathologic Neovascularization 01/2017 - 07/2012
2	Asthma (Bronchial Asthma) 03/2016 - 10/2012
2	Wounds and Injuries (Trauma) 12/2014 - 12/2014
2	Hyperplasia 12/2014 - 12/2004
2	Hypoxia (Hypoxemia) 08/2014 - 01/2014
2	Radiation Injuries (Radiation Sickness) 02/2014 - 01/2014
2	Neuralgia (Stump Neuralgia) 09/2013 - 01/2013
2	Carcinoma (Carcinomatosis) 05/2011 - 01/2005

Drug/Important Bio-Agent (IBA)

29	Pharmaceutical PreparationsIBA 01/2022 - 03/2007
19	Androgen Receptors (Androgen Receptor)IBA 02/2021 - 08/2002
16	Tubulin ModulatorsIBA 01/2022 - 07/2012
15	TubulinIBA 01/2022 - 11/2010
14	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2010
11	AndrogensIBA 01/2014 - 12/2004
10	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2010
10	Biological ProductsIBA 12/2021 - 10/2004
8	AmidesIBA 10/2010 - 10/2004
7	LigandsIBA 11/2019 - 04/2006
6	taxaneIBA 12/2020 - 11/2012
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2018 - 11/2010
6	Retinaldehyde (Retinal)IBA 01/2017 - 05/2012
6	Androgen Antagonists (Antiandrogens)IBA 10/2014 - 12/2004
6	1,2,3,4-tetrahydroisoquinolineIBA 09/2014 - 09/2006
5	Colchicine FDA LinkGeneric 01/2022 - 10/2010
5	Hormones (Hormone)IBA 01/2022 - 08/2002
5	hydroxide ionIBA 12/2021 - 01/2011
5	sabizabulinIBA 01/2021 - 01/2019
5	lysophosphatidic acidIBA 03/2016 - 07/2007
5	Lysophosphatidic Acid ReceptorsIBA 03/2016 - 07/2007
5	AcidsIBA 10/2010 - 04/2005
5	Cytotoxins (Cytolysins)IBA 10/2010 - 11/2004
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 05/2009
4	CollagenIBA 12/2021 - 12/2014
4	Calcitriol (Calcijex)FDA LinkGeneric 12/2021 - 02/2009
4	enzalutamideIBA 12/2021 - 01/2019
4	LuciferasesIBA 01/2020 - 01/2005
4	LipidsIBA 11/2017 - 09/2013
4	Estrogen ReceptorsIBA 01/2017 - 10/2010
4	Quinic Acid (Quinate)IBA 02/2014 - 11/2011
4	Testosterone (Sustanon)FDA Link 03/2012 - 04/2005
4	EDL-155IBA 07/2010 - 05/2008
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2021
3	SurvivinIBA 11/2021 - 01/2015
3	Vitamin D FDA LinkGeneric 08/2021 - 07/2015
3	ABI-274IBA 01/2021 - 11/2012
3	MicellesIBA 01/2019 - 09/2009
3	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2010
3	Caspase 3 (Caspase-3)IBA 12/2014 - 09/2009
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2014 - 04/2005
3	embelinIBA 09/2014 - 09/2009
3	Dacarbazine (DIC)FDA LinkGeneric 11/2012 - 01/2010
3	Serine (L-Serine)FDA Link 03/2007 - 10/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2011
2	Matrix Metalloproteinases (MMPs)IBA 12/2021 - 01/2020
2	Estrogens (Estrogen)FDA Link 02/2021 - 03/2012
2	VemurafenibIBA 01/2021 - 01/2014
2	pyridineIBA 01/2020 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2019 - 11/2017
2	monomethoxypolyethylene glycol (MPEG)IBA 01/2019 - 11/2012
2	Apoptosis Regulatory ProteinsIBA 04/2018 - 01/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 01/2015
2	Insulin-Like Growth Factor Binding Protein 3IBA 12/2014 - 05/2012
2	Dihydrotachysterol (AT 10)IBA 12/2014 - 11/2010
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2014 - 03/2012
2	N- (4- cyano- 3- (trifluoromethyl)phenyl)- 3- ((4- cyanophenyl)(methyl)amino)- 2- hydroxy- 2- methylpropanamideIBA 10/2014 - 08/2012
2	alkylglycerophosphoethanolamine phosphodiesteraseIBA 09/2013 - 12/2010
2	BenzopyransIBA 09/2013 - 07/2012
2	SecosteroidsIBA 01/2013 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2013 - 08/2010
2	Antimitotic AgentsIBA 11/2012 - 11/2010
2	indoleIBA 07/2012 - 02/2011
2	Acridine OrangeIBA 06/2012 - 07/2010
2	diphenyl (biphenyl)IBA 03/2012 - 09/2006
2	ThiazolesIBA 07/2011 - 06/2009
2	Multidrug Resistance-Associated ProteinsIBA 02/2011 - 11/2010

Therapy/Procedure

32	Therapeutics 01/2022 - 05/2009
9	Castration 02/2021 - 04/2005
8	Drug Therapy (Chemotherapy) 11/2021 - 05/2011
2	Aftercare (After-Treatment) 06/2012 - 01/2010